COVID-19 - search results

One year later and the new coronavirus is still posing new questions for researchers. The recent emergence of new COVID-19 variants across the world has left scientists searching for answers once again as they try to understand what these changes mean for the pandemic — and vaccine roll-outs.

Following the festive season, President Cyril Ramaphosa announced new measures to deal with the rising number of coronavirus infections. Find out the latest developments in South Africa’s planned response to the epidemic.

As countries around the world begin preparing their plans for rolling out a COVID vaccine, one group remains on the sidelines — children. With some candidates only recently receiving emergency approval for use in adults, they are still in the early stages of seeing how these jabs will work in children. But some paediatricians think it’s worth waiting.

President Cyril Ramaphosa will address the nation at 8 pm on Monday on developments in relation to the country’s response to the coronavirus pandemic.

With the first COVID jabs beginning to roll out, South Africa has announced its plan to reach two-thirds of the population once doses reach our shores. The country is expecting to receive its first share of available shots within the second quarter of this year. Here’s a look at who will get it and how.

Now that the world has its first effective COVID jabs, the next challenge we have to tackle is who gets them? Here’s why the public could be key to answering this complex question in South Africa.

The Aurum Institute has been selected as the new host for the South African Health Technologies Advocacy Coalition (SAHTAC) — a coalition of civil...

The end of the year is expected to see a lot of people heading home for the holidays, along with a rise of COVID-19 cases. Here’s why the solution for curbing the spread of this coronavirus could lie in harm reduction policies.

The race for a COVID vaccine has four candidates nearing the finish line — with some getting ready to roll out before the end of the year. But what do the reported efficacy results actually mean and how much will doses cost? We break it down.

Developing nations have the capacity to scale up their responses to the COVID-19 pandemic but they're continually hamstrung by barriers set up by Big Pharma.

A new study shows that female rape survivors are 60% more likely to contract HIV within a year or two after their rape than women who have not been raped.

Yvette Raphael describes herself as a ‘professional protester, sjambok feminist and hater of trash’. Government officials would likely refer to her as ‘a rebel’. She’s fought for equality her entire life, she says. And she’s scared of no one.

Four COVID jabs’ efficacy results have been released within less than a year after the trials had started. But this is far from the norm. Researchers have been working on HIV vaccines for over three decades — and we still don’t have one. Here’s why.

Mathematicians are exploring models to figure out how COVID vaccines should be distributed to have the biggest impact. Should they give it to older people to prevent deaths or to young adults - the main spreaders - to slow down infection rates? 

Residents of Masakhane in eMalahleni have never had running water. Instead they have to use buckets and wheelbarrows to carry water from one of the 33 JoJo tanks in the area. But these tanks are not filled regularly, leaving community members to wonder when they’ll next have access to this basic service.

It’s been almost 40 years since a new class of antibiotics was discovered. Do governments need to incentivise drug companies differently to get them to develop antibiotics to turn the tide against drug-resistant superbugs?